[Action of a 2.2 percent solution of androsterone, in chlorphenisate, on the serum lipoproteins of low density (LDL) in patients resistant to diet therapy].
D000328:Adult; D000368:Aged; D000738:Androsterone / Q000627:therapeutic use*; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D002087:Butyrates / Q000627:therapeutic use*; D003327:Coronary Disease / Q000188:drug therapy*; D005260:Female; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D008055:Lipids; D008074:Lipoproteins; D008297:Male; D008875:Middle Aged
D000924:Anticholesteremic Agents; D002087:Butyrates; D008055:Lipids; D008074:Lipoproteins; D000738:Androsterone
Ação da solução a 2.2 percentagem de androsterona, em clorofenisato, sôbre as lipoproteínas séricas de baixa densidade (LDL), em pacientes resistentes à dietoterapia.